Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle 25B phosphatase (CDC25B) is a dual-specificity phosphatase that plays a critical role in cell cycle regulation, particularly in controlling the transition from G2 phase to mitosis (M phase). It activates cyclin-dependent kinase 1 (CDK1, also known as CDC2) by dephosphorylating inhibitory sites, which is essential for mitotic entry. CDC25B exhibits oncogenic properties, and is a considered a potential therapeutic target in cancer treatment strategies aiming to disrupt aberrant cell division.
Inhibition of CDC25B phosphatase activity, leading to cell cycle arrest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle 25B phosphatase (CDC25B).